Grant: Engage Grants Program
University of Saskatchewan
$24,968.00
Ozonation of pharmaceuticals in the presence of natural organic matter (NOM)
EF 2011-12
Résumé
We are requesting funding to conduct an experimental work on process of degradation of model compound
pharmaceuticals using ozone in the presence of natural organic matter (NOM) in water. A local Canadian
company that works on developing ozone based technologies for sterilization and sanitation is our industrial
partner for the first time. The outcome of this work can contribute to improving performance of ozonative
waste treatment facilities and reducing cost of operation.
Presence of residual active chemicals from pharmaceuticals and personal care products (micropollutants,
emerging pollutants) in the environment is a source of concern. Oxidation with ozone is one of the most
effective methods to eliminate micropollutants in water. However, in most of the studies reported in literature,
the target micropollutant is treated with ozone in pure water. Effect of presence of natural organic matter
(NOM) that can act as an ozone consumer as well as inhibitor is not addressed. Treatment of pharmaceuticals
in the presence of NOM is similar to the problem of treatment of wastes from health care facilities that contain
both pharmaceuticals and components that can be represented with NOM.
The outcome of this research can contribute to development of more effective and low cost waste treatment
technologies that can help maintain high living and environmental standards for Canadians. The outcome of
this research will help our industrial partner -a Small and Medium Enterprise, SME- to be more competitive in
global market. This research will provide unique high quality personnel (HQP) training opportunity for our
students and trainees.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
417950-2011
Name nom
Soltan, Jafar
Department département
Chemical Engineering
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
24968
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
400
Area of application group en
Environment
Area of application group fr
Environnement
Area of application en
Environment
Area of application fr
Environnement
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Partie
1
Nb partie
1
Application title
Ozonation of pharmaceuticals in the presence of natural organic matter (NOM)
Keyword
NSERC
Application summary
We are requesting funding to conduct an experimental work on process of degradation of model compound
pharmaceuticals using ozone in the presence of natural organic matter (NOM) in water. A local Canadian
company that works on developing ozone based technologies for sterilization and sanitation is our industrial
partner for the first time. The outcome of this work can contribute to improving performance of ozonative
waste treatment facilities and reducing cost of operation.
Presence of residual active chemicals from pharmaceuticals and personal care products (micropollutants,
emerging pollutants) in the environment is a source of concern. Oxidation with ozone is one of the most
effective methods to eliminate micropollutants in water. However, in most of the studies reported in literature,
the target micropollutant is treated with ozone in pure water. Effect of presence of natural organic matter
(NOM) that can act as an ozone consumer as well as inhibitor is not addressed. Treatment of pharmaceuticals
in the presence of NOM is similar to the problem of treatment of wastes from health care facilities that contain
both pharmaceuticals and components that can be represented with NOM.
The outcome of this research can contribute to development of more effective and low cost waste treatment
technologies that can help maintain high living and environmental standards for Canadians. The outcome of
this research will help our industrial partner -a Small and Medium Enterprise, SME- to be more competitive in
global market. This research will provide unique high quality personnel (HQP) training opportunity for our
students and trainees.